Patient-reported outcomes (PROs) underrepresented in summaries of product characteristics (SmPCs) on new drugs
Before a new drug enters the market, the pharmaceutical company must submit a summary of product characteristics (SmPC) as part of marketing authorization. This should contain all relevant study data and information on the ...
Dec 15, 2021
0
1